[Relation Between COVID-19 and Guillain-Barré Syndrome in Adults. Systematic Review]

Overview

Journal Neurologia

Specialty Neurology

Date 2024 Apr 15

PMID 38620631

Authors

L M Trujillo Gittermann

S N Valenzuela Feris

A von Oetinger Giacoman

Affiliations

Soon will be listed here.

Abstract

Introduction: Numerous cases have been reported of patients with symptoms of Guillain-Barré syndrome associated with COVID-19, but much information is still lacking on this association and its implications. The objective of this review is to analyse the available evidence on this topic in the adult population.

Material And Methods: A systematic review was conducted of studies published on scientific databases: PubMed, Cochrane, Science Direct, Medline, and WHO COVID-19 database.

Results: We identified 47 studies, which were analysed and completed using the Covidence platform; the final analysis included 24 articles, with a total of 30 patients.

Conclusions: We found a strong association between both conditions; furthermore, the studies analysed highlight differences in the presentation of the disease, with greater severity of symptoms in Guillain-Barre syndrome associated with COVID-19.

References

Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S . Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020; 41(6):1351-1354. PMC: 7216127. DOI: 10.1007/s10072-020-04449-8. View

Filatov A, Sharma P, Hindi F, Espinosa P . Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus. 2020; 12(3):e7352. PMC: 7170017. DOI: 10.7759/cureus.7352. View

Arnaud S, Budowski C, Tin S, Degos B . Post SARS-CoV-2 Guillain-Barré syndrome. Clin Neurophysiol. 2020; 131(7):1652-1654. PMC: 7212990. DOI: 10.1016/j.clinph.2020.05.003. View

Letko M, Marzi A, Munster V . Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020; 5(4):562-569. PMC: 7095430. DOI: 10.1038/s41564-020-0688-y. View

Needham E, Chou S, Coles A, Menon D . Neurological Implications of COVID-19 Infections. Neurocrit Care. 2020; 32(3):667-671. PMC: 7188454. DOI: 10.1007/s12028-020-00978-4. View

Oguz-Akarsu E, Ozpar R, Mirzayev H, Acet-Ozturk N, Hakyemez B, Ediger D . Guillain-Barré Syndrome in a Patient With Minimal Symptoms of COVID-19 Infection. Muscle Nerve. 2020; 62(3):E54-E57. PMC: 7300697. DOI: 10.1002/mus.26992. View

. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41(2):145-151. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003. View

Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F . Guillain-Barré syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020; 7(5). PMC: 7286648. DOI: 10.1212/NXI.0000000000000785. View

Reyes-Bueno J, Garcia-Trujillo L, Urbaneja P, Ciano-Petersen N, Postigo-Pozo M, Martinez-Tomas C . Miller-Fisher syndrome after SARS-CoV-2 infection. Eur J Neurol. 2020; 27(9):1759-1761. PMC: 7300794. DOI: 10.1111/ene.14383. View

10.

Rana S, Lima A, Chandra R, Valeriano J, Desai T, Freiberg W . Novel Coronavirus (COVID-19)-Associated Guillain-Barré Syndrome: Case Report. J Clin Neuromuscul Dis. 2020; 21(4):240-242. PMC: 7273962. DOI: 10.1097/CND.0000000000000309. View

11.

Su X, Palka S, Rao R, Chen F, Brackney C, Cambi F . SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia. Muscle Nerve. 2020; 62(2):E48-E49. PMC: 7283744. DOI: 10.1002/mus.26988. View

12.

Li Y, Bai W, Hashikawa T . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92(6):552-555. PMC: 7228394. DOI: 10.1002/jmv.25728. View

13.

Rodriguez Y, Rojas M, Pacheco Y, Acosta-Ampudia Y, Ramirez-Santana C, Monsalve D . Guillain-Barré syndrome, transverse myelitis and infectious diseases. Cell Mol Immunol. 2018; 15(6):547-562. PMC: 6079071. DOI: 10.1038/cmi.2017.142. View

14.

Esteban Molina A, Mata Martinez M, Sanchez Chueca P, Carrillo Lopez A, Sancho Val I, Sanjuan-Villarreal T . [Guillain-Barré Syndrome Associated with SARS-CoV-2 infection]. Med Intensiva (Engl Ed). 2020; 44(8):513-514. PMC: 7198200. DOI: 10.1016/j.medin.2020.04.015. View

15.

El Otmani H, El Moutawakil B, Rafai M, El Benna N, El Kettani C, Soussi M . Covid-19 and Guillain-Barré syndrome: More than a coincidence!. Rev Neurol (Paris). 2020; 176(6):518-519. PMC: 7180370. DOI: 10.1016/j.neurol.2020.04.007. View

16.

Camdessanche J, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E . COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris). 2020; 176(6):516-518. PMC: 7158797. DOI: 10.1016/j.neurol.2020.04.003. View

17.

Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Cheema T . Guillain-Barré Syndrome associated with SARS-CoV-2 infection. IDCases. 2020; 20:e00771. PMC: 7165113. DOI: 10.1016/j.idcr.2020.e00771. View

18.

Marta-Enguita J, Rubio-Baines I, Gaston-Zubimendi I . Fatal Guillain-Barre syndrome after infection with SARS-CoV-2. Neurologia (Engl Ed). 2020; 35(4):265-267. PMC: 7166023. DOI: 10.1016/j.nrl.2020.04.004. View

19.

Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M . New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. 2020; 41(7):1657-1658. PMC: 8849645. DOI: 10.1007/s10072-020-04484-5. View

20.

Padroni M, Mastrangelo V, Asioli G, Pavolucci L, Abu-Rumeileh S, Piscaglia M . Guillain-Barré syndrome following COVID-19: new infection, old complication?. J Neurol. 2020; 267(7):1877-1879. PMC: 7180646. DOI: 10.1007/s00415-020-09849-6. View